CSIMarket
 
Fortrea Holdings Inc   (NASDAQ: FTRE)
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

Fortrea Holdings Inc's Suppliers Performance

FTRE's Supply Chain




 
FTRE Costs vs Sales of Suppliers Growth Fortrea Holdings Inc's cost of sales deteriorated by -6.55 % year on year, sequentially cost of sales grew by 5.09 % in Q2.

More on FTRE Suppliers



Fortrea Holdings Inc's cost of sales deteriorated by -6.55 % year on year, sequentially cost of sales grew by 5.09 % in Q2.

More on FTRE Suppliers




Fortrea Holdings Inc's Comment on Supply Chain


The company relies on contract manufacturers, including Fortrea, for drug supply to clinical trial patients, as well as providers of licensing agreements, maintenance contracts, and other services. It also depends on third-party contract research organizations (CROs) and contract clinical personnel to deliver clinical services, particularly in regions with limited internal resources or high demand. Effective management of these third parties is critical to avoid negative impacts on the business. Additionally, the company depends on access to data from a wide range of providers offering geographic, therapeutic, and site datasets to support its services. It regularly evaluates these data sources to maintain access on commercially reasonable terms. Failure to secure necessary data or manage third-party relationships could materially harm the company’s operations.

Fortrea Holdings Inc's Comment on Supply Chain


The company relies on contract manufacturers, including Fortrea, for drug supply to clinical trial patients, as well as providers of licensing agreements, maintenance contracts, and other services. It also depends on third-party contract research organizations (CROs) and contract clinical personnel to deliver clinical services, particularly in regions with limited internal resources or high demand. Effective management of these third parties is critical to avoid negative impacts on the business. Additionally, the company depends on access to data from a wide range of providers offering geographic, therapeutic, and site datasets to support its services. It regularly evaluates these data sources to maintain access on commercially reasonable terms. Failure to secure necessary data or manage third-party relationships could materially harm the company’s operations.







FTRE's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Fortrea Holdings Inc 1,850.50 2,676.50 -85.20 14,300
SUBTOTAL 0.00 0.00 0.00 -


Sources: Fortrea Holdings Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Fortrea Holdings Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.